Pitavastatin-loaded bilosomes for oral treatment of hepatocellular carcinoma: a repurposing approach

Albeit its established efficacy as an anti-hyperlipidemic agent, pitavastatin (PIT) has been shown to have other various therapeutic effects. One of these effects is the anti-cancer activity against hepatocellular carcinoma (HCC). This effect has been evaluated in this study for the first time via i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kharouba, Maged, El-Kamel, Amal, Mehanna, Radwa, Thabet, Eman, Heikal, Lamia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467608/
https://www.ncbi.nlm.nih.gov/pubmed/36081339
http://dx.doi.org/10.1080/10717544.2022.2120925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467608/
https://www.ncbi.nlm.nih.gov/pubmed/36081339
http://dx.doi.org/10.1080/10717544.2022.2120925

Ejemplares similares